PROCEPT BioRobotics
- Market cap
- 1.03B
- P/E (TTM)i
- -9.18
- P/Bi
- 3.02
- EPSi
- -1.72
- Div yieldi
- 0.00%
- 52W posi
- 6%
Anonymous reader poll. Unscientific, not investment advice.
About PROCEPT BioRobotics
PROCEPT BioRobotics Corp. is a commercial-stage surgical robotics company, which engages in the development of transformative solutions in urology. It manufactures and sells the AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating BPH. The firm's proprietary AquaBeam Robotic System employs a single-use disposable handpiece to deliver its Aquablation therapy, which combines real-time, multidimensional imaging, personalized treatment planning, automated robotics and heat-free waterjet ablation for targeted and rapid removal of prostate tissue. The company was founded by Nikolai Aljuri and Rodney C. Perkins in 2007 and is headquartered in San Jose, CA.
- Founded
- 2007
- CEO
- Mr. Larry L. Wood
- Employees
- 888
- Headquarters
- San Jose, California, United States of America
- Fiscal year end
- 12-31
- Website
- procept-biorobotics.com
Company profile
- Exchange
- US
- Symbol
- PRCT
- Market-cap rank
- #3234
- Listing date
- 2021-09-15
- Market cap
- 1.03B
- Float cap
- 999.54M
- Shares out
- 57.27M
- Float shares
- 55.81M
Sectors & themes
Quote time 2026-10-08 09:00:45 · For reference only, not investment advice and not tailored to your situation.